Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Share News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: THG Surges After Raising Revenue Guidance

Mon, 26th Oct 2020 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Pearson, up 3.6%. UBS upgraded the education publisher to Buy from Neutral.

----------

AstraZeneca, up 1.1%. The Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, has been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so. The US Food & Drug Administration authorised the restart of the trials in the US, as they resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

----------

FTSE 100 - LOSERS

----------

Royal Dutch Shell 'A', down 1.6%, Shell 'B', down 1.5%. The oil major was tracking spot oil prices lower, quoted at USD40.78 a barrel Monday morning, down sharply from USD42.25 late Friday. Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak. "The return of just one million barrels per day of extra production to the world market has sent oil into a tailspin. It highlights how fragile sentiment is to the supply/demand balance of oil in international markets. A double-dip recession in Europe will add to the demand concerns," said Oanda Markets analyst Jeffery Halley.

----------

FTSE 250 - WINNERS

----------

Synthomer, up 2.5%. JPMorgan raised the speciality chemicals firm to Overweight from Neutral.

----------

FTSE 250 - LOSERS

----------

Beazley, down 2.5%. Morgan Stanley downgraded the insurer to Equal Weight from Overweight.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

THG Holdings, up 12%. The online retailing platform raised revenue guidance for 2020, following strong trading in the third quarter and continued momentum in the fourth quarter to date. THG said for the three months to the end of September, total revenue grew by 39% year-on-year to GBP378.1 million. The group reported growth across all businesses. The largest contributor was THG Beauty, which grew revenue by 45% to GBP157.5 million. However, it was the THG Lifestyle division which grew at the fastest percentage rate, with an 80% increase to GBP24.4 million. THG listed in London last month with a market capitalisation of GBP5.40 billion and at the time guided for annual revenue of GBP1.43 billion. As a result of the stronger quarterly performance, the group now expects revenue to be between GBP1.48 billion to GBP1.52 billion, reflecting a 30% to 33% increase from GBP1.14 billion the year before. "Longer-term excitement around the story is based on its Ingenuity platform which has been compared in some quarters to Ocado's online solution for global groceries firms. The Hut essentially picking up the IT and logistical requirements of the likes of PZ Cussons, Hotel Chocolat and Nestle," said AJ Bell's Russ Mould.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Advanced Oncotherapy, down 14% at 31.65 pence. The proton therapy provider said it intends to raise GBP7.7 million through a subscription, the proceeds of which will go towards strengthening the company's balance sheet and ensure its first LIGHT system is fully operational in 2021. The company said it will issue 25.7 million shares to clients of SI Capital and other investors at a price of 30p each. The issue price reflects a 18% discount to the company closing price on Friday at 37p. The newly issued shares will represent 7.7% of its enlarged issued share capital.

----------

Corcel, down 11% at 1.07 pence. The natural resource exploration and development company said it has raised GBP750,000 through the placing of 75 million shares at GBP0.01 per share. The placing price represents a 15% discount to Friday's closing price of 1.17 pence. London-based Corcel said the new cash will be used to exercise the option with Sinom Hong Kong Ltd to purchase the remaining AUD3.05 million - or GBP1.7 million - debt in Resource Mining Corp at a 65% discount, noting the the exercise of the option now entails the payment of AUD640,000 in cash and the issuance of 23.7 million shares to Sinom subsidiary Asia Pacific. The company added it will also use some of the proceeds to pursue additional opportunities in the battery metals space.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2018 13:11

Advanced Oncotherapy Partner Extends Deadline For Distributor Talks

LONDON (Alliance News) - Proton therapy system developer Advanced Oncotherapy PLC said Tuesday talks between a Chinese distributor and a further distributor in the country the

Read more
6 Feb 2017 08:11

Advanced Oncotherapy Shares Drop On Terminated Sinophi Deal

Read more
23 Jan 2017 11:09

Advanced Oncotherapy Says Scope Of Potential Financing Talks Expanded

Read more
29 Dec 2016 17:17

DIRECTOR DEALINGS SUMMARY: Advanced Oncotherapy Non-Executive Buys

Read more
21 Dec 2016 12:01

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Executive Ups Interest

Read more
29 Nov 2016 12:09

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Executive Buys Shares

Read more
24 Nov 2016 16:35

Advanced Oncotherapy To Complete Harley Street Work By March 2018

Read more
25 Oct 2016 14:11

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Executive Sells Shares

Read more
19 Oct 2016 09:56

Advanced Oncotherapy gets planning permission for Harley St site

(ShareCast News) - AIM-listed Advanced Oncotherapy has been granted planning permission by Westminster Council for a proton beam facility on Harley Street. The company, which develops next-generation proton therapy systems for cancer treatment, said the facility will make an important contribution t

Read more
30 Sep 2016 10:34

Advanced Oncotherapy raises £10m to fund first proton clinic in London

(ShareCast News) - AIM-listed Advanced Oncotherapy raised £10m from a share placing to fund the development of the first proton therapy centre in London. The company raised the funds through the issue of 10m shares of 25p each to a new price of 100p per share to new and existing shareholders. The co

Read more
6 Sep 2016 11:38

Advanced Oncotherapy appoints Richard Amos as medical physics director

(ShareCast News) - Developer of next-generation proton therapy systems for cancer treatment, Advanced Oncotherapy, announced on Tuesday that it has appointed Richard Amos as international director of medical physics, a non-board position, with effect from 1 November. The AIM-traded firm said Amos wa

Read more
12 Jul 2016 11:01

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Exec Buys More Shares

Read more
11 Jul 2016 11:57

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Executive Ups Interest

Read more
8 Jul 2016 07:54

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Executive Ups Stake

Read more
7 Jul 2016 17:05

DIRECTOR DEALINGS: Advanced Oncotherapy Non-Exec Director Ups Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.